Funding for this research was provided by:
Received: 13 November 2020
Accepted: 30 March 2021
First Online: 12 May 2021
: The email reminder for survey completion stated that the data from the survey will be used to gain a better understanding of patient family/HCP insights and perspectives, and would be published in a peer-reviewed medical publication. Potential participants were allowed to opt out of the survey.
: Not applicable.
: JCK has received honoraria from Novartis for conducting lectures and advisory board consultations. VV has participated in advisory boards and pharmaceutical industry-sponsored symposia for Arvelles, Bial, Eisai, Esteve, GSK, GW Pharmaceutical, Novartis, Newbridge, and UCB Pharma.